[HTML][HTML] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi… - Annals of Translational …, 2016 - ncbi.nlm.nih.gov
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
[PDF][PDF] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi, K Nakagawa - 2016 - researchgate.net
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
[引用][C] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi… - Annals of translational …, 2016 - pubmed.ncbi.nlm.nih.gov
[PDF][PDF] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi, K Nakagawa - Targeted Therapy for Lung … - fp.amegroups.cn
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi, K Nakagawa - Annals of Translational …, 2016 - europepmc.org
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
[HTML][HTML] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi… - Annals of Translational …, 2016 - atm.amegroups.org
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
[PDF][PDF] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi, K Nakagawa - 2016 - cdn.amegroups.cn
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi, K Nakagawa - Annals of Translational …, 2016 - europepmc.org
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
[PDF][PDF] Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi, K Nakagawa - Targeted Therapy for Lung … - fp.amegroups.cn
Treatment for advanced non-small cell lung cancer (NSCLC) depends on the molecular
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
characteristics of the tumor. Mutations of the gene for the epidermal growth factor receptor …
Is afatinib a treatment option for brain metastases in patients with EGFR mutation-positive non-small cell lung cancer?
S Watanabe, H Hayashi… - Annals of Translational …, 2016 - atm.amegroups.org
Abstract Treatment for advanced non-small cell lung cancer (NSCLC) depends on the
molecular characteristics of the tumor. Mutations of the gene for the epidermal growth factor …
molecular characteristics of the tumor. Mutations of the gene for the epidermal growth factor …